Santos David A has filed 21 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 19430 shares of RIGEL PHARMACEUTICALS INC ($RIGL) on February 17, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Common Stock | 19430 | $0.00 | 62,870.0000 | 18,840,000 | 44.73% | 0.10% |
| Feb. 10, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | F | Common Stock | 3546 | $34.62 | 43,440.0000 | 18,840,000 | 7.55% | 0.02% |
| Feb. 2, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | F | Common Stock | 5718 | $36.01 | 46,986.0000 | 18,840,000 | 10.85% | 0.03% |
| Sept. 15, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 7394 | $0.00 | 7,394.0000 | 18,162,000 | 9999.99% | 0.04% |
| March 17, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 6875 | $0.00 | 6,875.0000 | 17,687,000 | 9999.99% | 0.04% |
| March 17, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 7850 | $0.00 | 7,850.0000 | 17,687,000 | 9999.99% | 0.04% |
| Feb. 5, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | S | Common Stock | 1796 | $21.93 | 51,704.0000 | 17,687,000 | 3.36% | 0.01% |
| Feb. 4, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | S | Common Stock | 2125 | $20.92 | 53,500.0000 | 17,687,000 | 3.82% | 0.01% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 14788 | $0.00 | 14,788.0000 | 17,687,000 | 9999.99% | 0.08% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Common Stock | 19717 | $0.00 | 55,625.0000 | 17,687,000 | 54.91% | 0.11% |
| Nov. 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 8000 | $0.00 | 8,000.0000 | 17,648,000 | 9999.99% | 0.05% |
| Feb. 28, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 78500 | $0.00 | 78,500.0000 | 17,401,000 | 9999.99% | 0.45% |
| Feb. 28, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 17,401,000 | 9999.99% | 0.46% |
| Feb. 5, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | S | Common Stock | 8918 | $1.14 | 349,093.0000 | 17,401,000 | 2.49% | 0.05% |
| Feb. 2, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | S | Common Stock | 5601 | $1.13 | 358,011.0000 | 17,401,000 | 1.54% | 0.03% |
| Jan. 23, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 157000 | $0.00 | 157,000.0000 | 17,401,000 | 9999.99% | 0.90% |
| Jan. 23, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Common Stock | 209000 | $0.00 | 363,612.0000 | 17,401,000 | 135.18% | 1.20% |
| Feb. 2, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | S | Common Stock | 5388 | $1.66 | 144,612.0000 | 17,049,000 | 3.59% | 0.03% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Common Stock | 80000 | $0.00 | 150,000.0000 | 17,049,000 | 114.29% | 0.47% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 100,000.0000 | 17,049,000 | 100.00% | 0.29% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Santos David A | EVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 160000 | $0.00 | 160,000.0000 | 17,049,000 | 9999.99% | 0.94% |